CompletedNCT04200248
A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration
PHASE2 · 94 planned enrolment
- Countries listed
- 1
- Registry update
- June 8, 2023
immortal.lifeTrial registrations containing the exact intervention label RBM-007 Injectable Solution.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 94 planned enrolment
PHASE1 · PHASE2 · 5 planned enrolment
PHASE1 · PHASE2 · 9 planned enrolment